BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 9217798)

  • 1. The use of antidesmoglein stains in Mohs micrographic surgery. A potential aid for the differentiation of basal cell carcinoma from horizontal sections of the hair follicle and folliculocentric basaloid proliferation.
    Krunic AL; Garrod DR; Viehman GE; Madani S; Buchanan MD; Clark RE
    Dermatol Surg; 1997 Jun; 23(6):463-8. PubMed ID: 9217798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A unique basaloid proliferation encountered during Mohs surgery: potential pitfall for overdiagnosis of basal cell carcinoma.
    Patel NS; Johnston RB; Messina JL; Cherpelis BS
    Dermatol Surg; 2011 Aug; 37(8):1180-8. PubMed ID: 21668568
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of touch imprint cytology and Mohs frozen-section histology in the evaluation of Mohs micrographic surgical margins.
    Florell SR; Layfield LJ; Gerwels JW
    J Am Acad Dermatol; 2001 Apr; 44(4):660-4. PubMed ID: 11260543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery.
    Cherpelis BS; Turner L; Ladd S; Glass LF; Fenske NA
    Dermatol Surg; 2009 Jul; 35(7):1050-6. PubMed ID: 19469800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of residual basal cell carcinoma in patients who appear tumor free after biopsy.
    Holmkvist KA; Rogers GS; Dahl PR
    J Am Acad Dermatol; 1999 Oct; 41(4):600-5. PubMed ID: 10495384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data.
    Lawrence CM; Haniffa M; Dahl MG
    Br J Dermatol; 2009 Mar; 160(3):573-80. PubMed ID: 19210500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folliculocentric basaloid proliferation. The bulge (der Wulst) revisited.
    Leshin B; White WL
    Arch Dermatol; 1990 Jul; 126(7):900-6. PubMed ID: 2360837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dense inflammation does not mask residual primary basal cell carcinoma during Mohs micrographic surgery.
    Katz KH; Helm KF; Billingsley EM; Maloney ME
    J Am Acad Dermatol; 2001 Aug; 45(2):231-8. PubMed ID: 11464184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid HMB-45 staining in Mohs micrographic surgery for melanoma in situ and invasive melanoma.
    Menaker GM; Chiang JK; Tabila B; Moy RL
    J Am Acad Dermatol; 2001 May; 44(5):833-6. PubMed ID: 11312433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mohs micrographic surgery of primary cutaneous mucinous carcinoma using immunohistochemistry for margin control.
    Marra DE; Schanbacher CF; Torres A
    Dermatol Surg; 2004 May; 30(5):799-802. PubMed ID: 15099329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal cell carcinoma with matrical differentiation in a transplant patient: a case report and review of the literature.
    Ali F; Brown A; Gottwald L; Thomas J
    J Cutan Pathol; 2005 Jul; 32(6):445-8. PubMed ID: 15953381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
    Hendrix JD; Parlette HL
    Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal cell carcinoma with matrical differentiation: a case study with analysis of beta-catenin.
    Haskell HD; Haynes HA; McKee PH; Redston M; Granter SR; Lazar AJ
    J Cutan Pathol; 2005 Mar; 32(3):245-50. PubMed ID: 15701088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Sep; 53(3):458-63. PubMed ID: 16112353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer.
    Cohen PR; Schulze KE; Nelson BR
    Dermatol Surg; 2006 Apr; 32(4):542-51. PubMed ID: 16681663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical excision of basal cell carcinoma with complete margin control: outcome at 5-year follow-up.
    Wetzig T; Woitek M; Eichhorn K; Simon JC; Paasch U
    Dermatology; 2010; 220(4):363-9. PubMed ID: 20484877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of serial transverse cross-sections in detecting residual basal cell carcinoma at the surgical margins of an elliptical excision specimen.
    Kimyai-Asadi A; Goldberg LH; Jih MH
    J Am Acad Dermatol; 2005 Sep; 53(3):469-74. PubMed ID: 16112355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
    Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
    Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difference between pigmented and nonpigmented basal cell carcinoma treated with Mohs micrographic surgery.
    Aoyagi S; Nouri K
    Dermatol Surg; 2006 Nov; 32(11):1375-9. PubMed ID: 17083591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.